Clinical Trial Search

Primary: Number of Participants With Unacceptable Toxicity — 0; 0; 0; 0 participants

Primary: 2-Year Knee Society Score — 91.3; 94.2 units on a scale 0-100

Primary: Number of Participants With Cyst Recurrence — 3; 2 participants

Primary: Proprioception of the Knee Post Operation — 10.3; 6.3; 7.3; 6.4 units on a scale — p=<0.05

Primary: Mean Pain50 Assessed at Baseline, 3 Months and 6 Months — 4.3; 4.2; 4.2 kg/cm^2

Primary: Change From Baseline on Cognition, Assessed by the Alzheimer's Disease Assessment Scale-Cognitive (ADAS-Cog) — -0.5; -0.7 Scores on a scale

Primary: Weight — 103.8; 100.7 kg — p=0.44

Primary: Change From Baseline in Central Retinal Thickness in the Study Eye — 403.4; -38.9 Microns

Primary: Frequency of Staff Interventions for Hypoventilation. — 0.39; 0.396 Events per patient minute of sedation

Primary: Period 2: Number of Subjects Who Relapsed — 4; 10; 8; 14 participants

Primary: Proportion of Index Subjects Free of Any of Lice 14 Days After Their Last Treatment. — 82.98; 62.50 percentage of subjects — p=0.0386

Primary: Change From Baseline in Disease Activity Score Based on 28-Joint Count (DAS28) — 5.51; 4.39; -1.12 scores on a scale — p=<0.0001

Primary: Time to Healing (Days) — 13.1; NA; 13.1; NA days

Primary: Biochemical Verification of Tobacco Abstinence — 19; 47 participants

Primary: Change in Maximum Forced Expiratory Volume at One Second (FEV1) — 20; 20; 20; 19 percentage of change